Prediction of stroke in the general population in Europe (EUROSTROKE): Is there a role for fibrinogen and electrocardiography?
暂无分享,去创建一个
M L Bots | P C Elwood | Y Nikitin | K G M Moons | D E Grobbee | P. Elwood | D. Grobbee | Y. Nikitin | J. Salonen | M. Bots | D. Inzitari | P. Koudstaal | J. Tuomilehto | K. Moons | J. Sivenius | V. Benetou | P J Koudstaal | J T Salonen | J Tuomilehto | A Freire de Concalves | J Sivenius | D Inzitari | V Benetou | V. Benetou | A. Concalves | A. Freire de Concalves | P. Elwood
[1] F. Song,et al. Cholesterol lowering and mortality: the importance of considering initial level of risk. , 1993, BMJ.
[2] M. Mancini,et al. Measuring plasma fibrinogen to predict stroke and myocardial infarction. , 1990, Arteriosclerosis.
[3] K. Anderson,et al. An updated coronary risk profile. A statement for health professionals. , 1991, Circulation.
[4] Eaft Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke , 1993, The Lancet.
[5] J. Hanley,et al. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. , 1983, Radiology.
[6] P. Poole‐Wilson,et al. Prevention of coronary heart disease in clinical practice: recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. , 1994, Atherosclerosis.
[7] R D Cebul,et al. The importance of disease prevalence in transporting clinical prediction rules. The case of streptococcal pharyngitis. , 1986, Annals of internal medicine.
[8] P. Macfarlane,et al. West of Scotland Coronary Prevention Study: Identification of high-risk groups and comparison with other cardiovascular intervention trials , 1996 .
[9] L Wilhelmsen,et al. Analysis of risk factors for stroke in a cohort of men born in 1913. , 1987, The New England journal of medicine.
[10] Roderick J. A. Little. Regression with Missing X's: A Review , 1992 .
[11] Daniel B. Mark,et al. TUTORIAL IN BIOSTATISTICS MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS , 1996 .
[12] O S Miettinen,et al. Proportion of disease caused or prevented by a given exposure, trait or intervention. , 1974, American journal of epidemiology.
[13] V. Geissbühler,et al. Waterbirths: A Comparative Study , 2000, Fetal Diagnosis and Therapy.
[14] T. Lancet,et al. West of Scotland Coronary Prevention Study: identification of high-risk groups and comparison with other cardiovascular intervention trials , 1996, The Lancet.
[15] H. Mcintosh,et al. Smoking as a risk factor. , 1978, Heart & lung : the journal of critical care.
[16] The Treatment of Coronary Heart Disease: An Update , 2001, Current medical research and opinion.
[17] A. Fehily,et al. Caerphilly and Speedwell collaborative heart disease studies. The Caerphilly and Speedwell Collaborative Group. , 1984, Journal of epidemiology and community health.
[18] F. Harrell,et al. Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .
[19] Arno W. Hoes,et al. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. , 1997, Circulation.
[20] J. Bamford,et al. Classification and natural history of clinically identifiable subtypes of cerebral infarction , 1991, The Lancet.
[21] I. U. Haq,et al. Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease , 1995, The Lancet.
[22] H. Blackburn,et al. Cardiovascular survey methods. , 1969, Monograph series. World Health Organization.
[23] L. Wilhelmsen,et al. Fibrinogen as a risk factor for stroke and myocardial infarction. , 1984, The New England journal of medicine.
[24] T. Wyller,et al. Lifestyle Factors and Risk of Cerebral Infarction , 1992, Stroke.
[25] B. Efron. Estimating the Error Rate of a Prediction Rule: Improvement on Cross-Validation , 1983 .
[26] F. Harrell,et al. Regression models in clinical studies: determining relationships between predictors and response. , 1988, Journal of the National Cancer Institute.
[27] P. Poole‐Wilson,et al. Prevention of coronary heart disease in clinical practice , 1994 .
[28] P. Whincup,et al. Femoral atherosclerosis in an older British population: prevalence and risk factors. , 2000, Atherosclerosis.
[29] J A Kors,et al. Methodology of the Modular ECG Analysis System MEANS , 1990, Methods of Information in Medicine.
[30] R. Rauramaa,et al. HDL, HDL2, and HDL3 Subfractions, and the Risk of Acute Myocardial Infarction: A Prospective Population Study in Eastern Finnish Men , 1991, Circulation.
[31] D E Grobbee,et al. Does drug treatment improve survival? Reconciling the trials in mild‐to-moderate hypertension , 1995, Journal of hypertension.
[32] J. L. Willems,et al. The diagnostic performance of computer programs for the interpretation of electrocardiograms. , 1992, The New England journal of medicine.
[33] V. Salomaa,et al. The FINMONICA Stroke Register. Community-based stroke registration and analysis of stroke incidence in Finland, 1983-1985. , 1992, American journal of epidemiology.
[34] C. Bulpitt,et al. Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. , 1993, BMJ.
[35] I. U. Haq,et al. Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men , 1999, Heart.
[36] C. Warlow,et al. Fibrinogen and lipid concentrations as risk factors for transient ischaemic attacks and minor ischaemic strokes. , 1991, BMJ.
[37] P. Poole‐Wilson,et al. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. , 1994, European heart journal.
[38] I. U. Haq,et al. Sheffield risk and treatment table for cholesterol lowering in prevention of coronary heart disease , 1995, The Lancet.
[39] J. Hanley,et al. The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.
[40] E. DeLong,et al. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.
[41] A. Hofman,et al. Cardiovascular risk and all-cause mortality; A 12 year follow-up study in The Netherlands , 1993, European Journal of Epidemiology.
[42] Leandro Provinciali,et al. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke , 1993 .
[43] S Greenland,et al. A critical look at methods for handling missing covariates in epidemiologic regression analyses. , 1995, American journal of epidemiology.
[44] R S Wigton,et al. Transportability of a decision rule for the diagnosis of streptococcal pharyngitis. , 1986, Archives of internal medicine.
[45] A. Hofman,et al. Determinants of disease and disability in the elderly: The Rotterdam elderly study , 1991, European Journal of Epidemiology.
[46] N Rifai,et al. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. , 2001, JAMA.
[47] J Nyboe,et al. Stroke incidence and risk factors for stroke in Copenhagen, Denmark. , 1988, Stroke.
[48] Factor V Arg506Gln mutation is not associated with cardiovascular mortality in older women. , 1999, American journal of epidemiology.
[49] David W. Hosmer,et al. Applied Logistic Regression , 1991 .
[50] M. Elisaf. The Treatment of Coronary Heart Disease: An Update , 2001, Current medical research and opinion.
[51] T. Truelsen,et al. Comparison of Probability of Stroke Between the Copenhagen City Heart Study and the Framingham Study , 1994, Stroke.
[52] P. Koudstaal,et al. We need stronger predictors of major vascular events in patients with a recent transient ischemic attack or nondisabling stroke. Dutch TIA Trial Study Group. , 1997, Stroke.
[53] J. Ferro,et al. Incidence and risk factors of ischaemic and haemorrhagic stroke in Europe , 1996 .
[54] A. Hoes,et al. Prevalence, Determinants, and Misclassification of Myocardial Infarction in the Elderly , 1997, Epidemiology.
[55] R B D'Agostino,et al. Probability of stroke: a risk profile from the Framingham Study. , 1991, Stroke.